Terms: = Leukemia AND FANCC, ENSG00000158169, 2176, RP11-80I15_2, FAC, FA3, FACC, FLJ14675 AND Prognosis
6482 results:
1.
Wang JN; Ye B; Cheng F; Yang L; Hu Y; Zheng G; Cai Z; Yu J; Wu W
Hematology; 2024 Dec; 29(1):2423324. PubMed ID: 39499083
[TBL] [Abstract] [Full Text] [Related]
2. Impact of Simultaneous Presence of Multiple PML-RARA Isoforms on Phenotype in Patients with Acute Promyelocytic Leukaemia.
Goktas E; Zamani AG; Yildirim MS; Demircioglu S; Tekinalp A; Ceneli O
J Coll Physicians Surg Pak; 2024 Nov; 34(11):1552-1556. PubMed ID: 39491447
[TBL] [Abstract] [Full Text] [Related]
3. [Research Progress on Prognostic factors in Patients with Lower-Risk Myelodysplastic Syndrome--Review].
Liu JN; Chen BA; Cheng J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1626-1630. PubMed ID: 39479859
[TBL] [Abstract] [Full Text] [Related]
4. [Diagnosis and Risk Stratification of Acute Myeloid leukemia, Myelodysplasia -Related].
Yang H; Guo R; Shi Y; Qiao C; Wang Y; Wu YJ; Qiu HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1372-1376. PubMed ID: 39479818
[TBL] [Abstract] [Full Text] [Related]
5. [The Effects of
Shi XQ; Zhang PP; Guan YN; DU ZC; Chen Y; Huang P; He ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1365-1371. PubMed ID: 39479817
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical Characteristics and prognosis of Children with Hypodiploid B-cell Precursor Acute Lymphoblastic leukemia].
Chen CX; Weng KZ; Wen H; Zhuang SQ; Wu XG; Zheng YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1356-1364. PubMed ID: 39479816
[TBL] [Abstract] [Full Text] [Related]
7. [Association between Early Minimal Residual Disease Detected by Flow Cytometry and prognosis in Children with Acute Myeloid leukemia: A Clinical Retrospective Study].
Lu WJ; Xiong H; Yang L; Long F; Chen Z; Tao F; Sun M; Wang Z; Luo LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1343-1348. PubMed ID: 39479814
[TBL] [Abstract] [Full Text] [Related]
8. [Expression and Clinical Significance of Serum HDAC2 in Patients with Acute Myeloid leukemia].
Huang J; Yang JJ; Xu YC; Zhang HQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1317-1322. PubMed ID: 39479811
[TBL] [Abstract] [Full Text] [Related]
9. Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth.
Ghantous A; Nusslé SG; Nassar FJ; Spitz N; Novoloaca A; Krali O; Nickels E; Cahais V; Cuenin C; Roy R; Li S; Caron M; Lam D; Fransquet PD; Casement J; Strathdee G; Pearce MS; Hansen HM; Lee HH; Lee YS; de Smith AJ; Sinnett D; Håberg SE; McKay JA; Nordlund J; Magnus P; Dwyer T; Saffery R; Wiemels JL; Munthe-Kaas MC; Herceg Z
Mol Cancer; 2024 Oct; 23(1):238. PubMed ID: 39443995
[TBL] [Abstract] [Full Text] [Related]
10. [Application of serum tumor specific protein 70 for prognostic stratification in acute myeloid leukemia].
Huang YL; Jin F; Zhang LX; Mu Y; Lu FY; Xia WY; Zhu Q; Yang SX; Xu J; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Oct; 58(10):1541-1547. PubMed ID: 39428239
[No Abstract] [Full Text] [Related]
11. Prognostic impact of clonal hematopoiesis mutations at complete molecular remission in acute myeloid leukemia with NPM1 mutation.
Wang L; Shu M; Zhang Z; Dou X; Xu X; Ma Y; Wen L; Yang X; Chen S
J Cancer Res Clin Oncol; 2024 Oct; 150(10):465. PubMed ID: 39422784
[TBL] [Abstract] [Full Text] [Related]
12. [Infection of Aspergillus fumigatus after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: 2 cases report and literature review].
Zhao W; Chen M; Zhao YL
Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):848-850. PubMed ID: 39414609
[TBL] [Abstract] [Full Text] [Related]
13. Targeting USP14/UCHL5: A Breakthrough Approach to Overcoming Treatment-Resistant FLT3-ITD-Positive AML.
Nogami A; Amemiya HJ; Fujiwara H; Umezawa Y; Tohda S; Nagao T
Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408703
[TBL] [Abstract] [Full Text] [Related]
14. Elucidating the role of MLL1 nsSNPs: Structural and functional alterations and their contribution to leukemia development.
Al-Nakhle HH; Yagoub HS; Alrehaili RY; Shaqroon OA; Khan MK; Alsharif GS
PLoS One; 2024; 19(10):e0304986. PubMed ID: 39405275
[TBL] [Abstract] [Full Text] [Related]
15. EGCG enhances antitumor effect of apatinib in nonsmall cell lung cancer by targeting VEGF signaling to inhibit glycolysis.
Zhou Y; Qin L; Li C; Zhu D; Liu B
Drug Dev Res; 2024 Nov; 85(7):e22239. PubMed ID: 39397333
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathological features and treatment of aggressive natural killer cell leukemia: case series and literature review.
Ni Y; Li L; Wang Y; Sun L
Turk J Pediatr; 2024 Oct; 66(4):481-489. PubMed ID: 39387420
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive multi-omics analysis of the prognostic value and immune signature of NCF2 in pan-cancer and its relationship with acute myeloid leukemia.
Zhong F; Zeng Y; Yan Y; Guo L; Guo Q; Liu W; Liu C
Int Immunopharmacol; 2024 Dec; 143(Pt 1):113364. PubMed ID: 39393272
[TBL] [Abstract] [Full Text] [Related]
18. Reactive oxygen species and aldehyde dehydrogenase 1A as prognosis and theragnostic biomarker in acute myeloid leukaemia patients.
Venton G; Colle J; Tichadou A; Quessada J; Baier C; Labiad Y; Perez M; De Lassus L; Loosveld M; Arnoux I; Abbou N; Ceylan I; Martin G; Costello R
J Cell Mol Med; 2024 Oct; 28(19):e70011. PubMed ID: 39392121
[TBL] [Abstract] [Full Text] [Related]
19. CBFA2T3-GLIS2 mediates transcriptional regulation of developmental pathways through a gene regulatory network.
Garfinkle EAR; Nallagatla P; Sahoo B; Dang J; Balood M; Cotton A; Franke C; Mitchell S; Wilson T; Gruber TA
Nat Commun; 2024 Oct; 15(1):8747. PubMed ID: 39384814
[TBL] [Abstract] [Full Text] [Related]
20. [Report of six cases with mast cell leukemia and a literature review].
Zhu F; Yu Y; Chen CY; Duan WB; Jiang Q; Yan R; Sun Y; Han YQ; Zhang J; Wang H; Zhang QR; Chen SN; Yan WH; Cai MJ; Zhang ZB; Yin J; Wang Q
Zhonghua Nei Ke Za Zhi; 2024 Oct; 63(10):996-1000. PubMed ID: 39375119
[TBL] [Abstract] [Full Text] [Related]
[Next]